Escitalopram tolerability as mono- versus augmentative therapy in patients with affective disorders: a naturalistic study

Bibliographic Details
Main Authors: Dell’Osso, Bernardo, Arici, Chiara, Dobrea, Cristina, Camuri, Giulia, Benatti, Beatrice, Altamura, A Carlo
Format: Online
Language:English
Published: Dove Medical Press 2013
Online Access:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3573802/
id pubmed-3573802
recordtype oai_dc
spelling pubmed-35738022013-02-21 Escitalopram tolerability as mono- versus augmentative therapy in patients with affective disorders: a naturalistic study Dell’Osso, Bernardo Arici, Chiara Dobrea, Cristina Camuri, Giulia Benatti, Beatrice Altamura, A Carlo Short Report Dove Medical Press 2013 2013-02-08 /pmc/articles/PMC3573802/ /pubmed/23429980 http://dx.doi.org/10.2147/NDT.S39322 Text en © 2013 Dell’Osso et al, publisher and licensee Dove Medical Press Ltd This is an Open Access article which permits unrestricted noncommercial use, provided the original work is properly cited.
repository_type Open Access Journal
institution_category Foreign Institution
institution US National Center for Biotechnology Information
building NCBI PubMed
collection Online Access
language English
format Online
author Dell’Osso, Bernardo
Arici, Chiara
Dobrea, Cristina
Camuri, Giulia
Benatti, Beatrice
Altamura, A Carlo
spellingShingle Dell’Osso, Bernardo
Arici, Chiara
Dobrea, Cristina
Camuri, Giulia
Benatti, Beatrice
Altamura, A Carlo
Escitalopram tolerability as mono- versus augmentative therapy in patients with affective disorders: a naturalistic study
author_facet Dell’Osso, Bernardo
Arici, Chiara
Dobrea, Cristina
Camuri, Giulia
Benatti, Beatrice
Altamura, A Carlo
author_sort Dell’Osso, Bernardo
title Escitalopram tolerability as mono- versus augmentative therapy in patients with affective disorders: a naturalistic study
title_short Escitalopram tolerability as mono- versus augmentative therapy in patients with affective disorders: a naturalistic study
title_full Escitalopram tolerability as mono- versus augmentative therapy in patients with affective disorders: a naturalistic study
title_fullStr Escitalopram tolerability as mono- versus augmentative therapy in patients with affective disorders: a naturalistic study
title_full_unstemmed Escitalopram tolerability as mono- versus augmentative therapy in patients with affective disorders: a naturalistic study
title_sort escitalopram tolerability as mono- versus augmentative therapy in patients with affective disorders: a naturalistic study
description
publisher Dove Medical Press
publishDate 2013
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3573802/
_version_ 1611955325878927360